Early Pregnancy Safety Concerns With ACE Inhibitors Could Affect ARBs
Executive Summary
Concerns about exposure to angiotensin-converting enzyme inhibitors during the first trimester of pregnancy could have consequences for other classes of antihypertensives, including angiotensin II receptor blockers
You may also be interested in...
Rx Safety Gets More Attention From CERTs With Addition Of Health IT Center
The Centers for Education and Research on Therapeutics program will be adding a new center focused on health information technology
Rx Safety Gets More Attention From CERTs With Addition Of Health IT Center
The Centers for Education and Research on Therapeutics program will be adding a new center focused on health information technology
Pregnancy Label Due Date Approaching? Risk, Clinical Info Could Be Split
FDA is seeking to move ahead quickly with new regulations for pregnancy labeling following the release of the physician labeling final rule